Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Kylin Therapeutics Signs Collaboration with Fort Dodge Animal Health, a Division of Wyeth

Abstract:


Kylin To Use Its pRNA Technology to Help Develop New RNAi Therapeutics to Treat Cancer

Kylin Therapeutics Signs Collaboration with Fort Dodge Animal Health, a Division of Wyeth

WEST LAFAYETTE, IN | Posted on September 20th, 2007

Kylin Therapeutics, Inc., a biotechnology company, announced it has signed a collaboration with Fort Dodge Animal Health, a division of Wyeth (NYSE:WYE), to develop new RNAi therapeutics for the treatment of cancer. Under the terms of the three-year contract, Kylin will receive research funding, milestone payments and royalties.

Under this contract, Kylin will use its patented RNA nanoparticle technology called "pRNA" to explore the enormous potential of RNA interference (RNAi) and develop new RNA-based therapeutics for the treatment of cancer. In return for its participation in this effort, Fort Dodge will receive an exclusive license to the pRNA/RNAi therapeutic compounds for the treatment of cancers in companion animals. Kylin will retain rights to the therapies for human use.

"We are delighted to welcome Fort Dodge/Wyeth as Kylin's partner. Our business models are complementary, and the results of this effort will provide valuable data and intellectual property that will mutually serve our core businesses," said J. Eric Davis, J.D., president and CEO of Kylin Therapeutics.

The pRNA technology was developed by Peixuan Guo at Purdue University.

####

About Kylin Therapeutics, Inc.
About Kylin Therapeutics

Kylin ( http://www.kylintherapeutics.com ), which is based at the Purdue Research Park, is a leading biotechnology company focused on delivery and development of RNAi based therapeutics. The company employs its revolutionary RNA nanotechnology platform called "pRNA" to develop the potential of RNA interference (RNAi) to treat many common diseases. Kylin's technology platform has the potential to meet the growing market for treating cancer, HIV and other diseases with RNA-based therapeutics.

About Fort Dodge/Wyeth

Fort Dodge Animal Health is a leading manufacturer and distributor of animal health products for the livestock, companion animal, equine, swine and poultry industries in North America and international markets. Key products include CYDECTIN® Pour-On, QUEST® Gel, the Duramune and Fel-O-Vax® vaccine lines, and West-Nile Innovator® equine vaccines. Fort Dodge is headquartered in Overland Park, Kan.

For more information, please click here

Contacts:
Purdue Research Foundation
Marketing and Communication Contact:
Cynthia Sequin, 765-494-4192 (office)
765-413-6031 (mobile)

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Alliances/Trade associations/Partnerships/Distributorships

Manchester graphene spin-out signs $1billion game-changing deal to help tackle global sustainability challenges: Landmark deal for the commercialisation of graphene April 14th, 2023

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022

Research partnerships

Researchers’ approach may protect quantum computers from attacks March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

'Sudden death' of quantum fluctuations defies current theories of superconductivity: Study challenges the conventional wisdom of superconducting quantum transitions January 12th, 2024

Development of zinc oxide nanopagoda array photoelectrode: photoelectrochemical water-splitting hydrogen production January 12th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project